Submission of Annual Report for the FY 2024-25 comprising of the Notice of Annual General Meeting, Directors Report, Independent Auditors Report and Audited Financial Statements (Standalone ....

Revenue growth above 20%Profit growth above 25%EBITDA margin expansionRelated-party transactionsResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.4%Reaction day

₹271.95

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.0%+0.4% vs market

Medical Equipment & Supplies peers, median of 11sector+0.0%+0.4% vs sector

On the reaction day the stock moved 0.4 pts more than Nifty Microcap 250 and 0.4 pts more than its Medical Equipment & Supplies peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.4-0.0+0.4+0.0+0.4

Next day

-1.0+0.4-1.5+0.3-1.3

-1.5+0.6-2.0-1.9+0.4

-0.7+1.0-1.7+0.6-1.3

-5.7+0.9-6.6-1.8-3.8

-6.3+0.8-7.2-1.1-5.2

-6.3+2.2-8.5+0.7-7.1

15d

—-1.7—-3.3—

-9.9-0.5-9.4-4.9-5.0

-11.7-0.5-11.3-6.2-5.6

-9.7-4.7-4.9-6.6-3.1

UpDownMarket · Nifty Microcap 250Sector · Medical Equipment & Supplies peers, median of 11Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Royal Sense Limited, a Delhi-based medical devices and healthcare products distributor listed on the BSE SME platform, has submitted its 2nd Annual Report for FY 2024-25 ahead of its AGM scheduled for September 29, 2025 via video conferencing. On a standalone basis, revenue from operations rose to ₹2,764.31 lakhs from ₹1,896.39 lakhs, while profit after tax climbed to ₹304.49 lakhs from ₹170.19 lakhs (the company reports a 55.89% rise). On a consolidated basis, including subsidiary Stergic Retail Pvt Ltd, revenue jumped sharply to ₹6,173.40 lakhs from ₹1,780.02 lakhs, and PAT surged to ₹633.12 lakhs from ₹158.88 lakhs. EBITDA margin expanded to 14.52% from 12.91%, and return on equity rose to 24.76% from 8.72%. The company raised funds via preferential issue of 4.5 lakh convertible warrants at ₹151 each, and increased authorised capital from ₹5 crore to ₹10 crore. No dividend was declared. Statutory and secretarial auditors reported no qualifications or adverse remarks.

Likely market impact

Strong top-line and bottom-line growth, expanding margins and a sharp jump in ROE signal healthy business momentum, which is positive for shareholders. However, the stock trades on the BSE SME platform (lower liquidity), no dividend is declared, and a proposed merger with TTG Innovations Pvt Ltd was rejected by BSE (fresh application pending), so investors should weigh execution risks.